Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,500 employees and serves more than 85,000 research and industry customers worldwide through its global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.

Quest Diagnostics Investments LLC, a subsidiary of Quest Diagnostics, Inc., is an American company specializing in medical laboratories.

Handan Kangye Biotechnology Co., Ltd., established on 2012-06-20, Business scope includes biotechnology development,Biotechnology Services,Genetic testing product sales and services;R&D of medical devices,Production,Sales;Health food sales(Operating with a food business license)*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.

Shanghai Xinpeijing Medical Laboratory Co., Ltd., established on 2004-09-28, Business scope includes for-profit medical institutions,engaged in biotechnology,Technology development in the field of medical technology,technology transfer,technical consulting,Technical Services,Sales of Medical Devices,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Bohao Yuntian Zhizao (Beijing) Technology Co., Ltd., established on 2019-08-16, Business scope includes biotechnology extension services;Medical Research and Experimental Development;Sales of medical devicesΙ,Class II,Instrumentation,Equipment,electronic product,Chemical Products,chemical reagent,computer,Software and Auxiliary Equipment;software development;computer system integration;Computer System Services;Production of medical devices Class I;Sales of Class III medical devices;Production Class II,Class III medical device.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production Class II,Class III medical device,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing on prenatal screening, supplemented by newborn screening and prenatal diagnosis, and deeply creating the most complete high-throughput prevention and control of genetic diseases and birth defects Sequencing technology series of innovative products, leading enterprises and unicorn enterprises in the subdivision field. The company is headquartered in Beijing Economic and Technological Development Zone, has an overseas research center in Houston, the United States, and an R&D transformation center, GMP production base, and medical testing laboratory in Beijing.

Counsyl is a health technology company that offers DNA screening for men, women and their children. Our philosophy is simple - focus on diseases where advanced knowledge makes a difference in health outcomes, whether it's changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead. Counsyl has screened over 500,000 patients and served over 6,000 health professionals in its modern clinical laboratory. From the purely mechanical to profoundly human, Counsyl strives to make DNA screening truly accessible to everyone. The team consists of world class engineers, scientists and clinical experts as well as a renowned engineering and scientific advisory board. Counsyl integrates sophisticated technology with custom robotic automation in its accredited medical laboratory. This focus on technology has made Counsyl a leader in helping patients and doctors communicate about medical results in real time. Its products have won the Wall Street Journal’s Innovation Award for Medicine, and have been named one of Scientific American's "Top 10 World Changing Ideas." Counsyl’s Family Prep Screen has already helped hundreds of thousands of people discover critical information before having children, and the Counsyl platform now extends beyond family preparation to include informed pregnancy and cancer screening.

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Chiron Diagnostics Corp., a subsidiary of Bayer AG, is a company headquartered in East Walpole, MA. The firm develops medical diagnostic products. On November 30, 1998 Bayer AG acquired Chiron Diagnostics Corp. from Chiron Corp. for $1,100 million.

Jiangsu Shengji Gene Technology Co., Ltd., established on 2017-07-24, Business scope includes technology development in the field of gene technology,technical consulting,Technical Services,technology transfer;Class I,Class II,Class III medical device research and development,Production,Sales.Import and export;Technology Import and Export;Import and export agency;Manufacturing of experimental analysis instruments;Medical equipment rental;software development;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;Health Consulting Services(Does not include medical services);Conference and Exhibition Services;Socioeconomic Advisory Services;marketing planning(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xinyi Manufacturing Technology (Beijing) Co., Ltd., established on 2016-12-19, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Class II Medical Device Leasing;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product production(No licensed chemical products);rental service(Licensed rental services not included);Specialty Chemicals Sales(Free of Hazardous Chemicals);Class I Medical Device Leasing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Clonatec SA is a French private company located in Paris. The firm manufactures diagnostic kits.

Guangdong Women & Children's Hospital & Health Institute is a private company headquartered in China. The firm provides hospitals and healthcare services.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Shanghai Jiemeng Biotechnology Co., Ltd., established on 2015-09-11, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,medical instruments(Except for approval),Instrumentation,mechanical equipment and electronic equipment,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),sales of cosmetics,account Serive,Exhibition display service,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Yancheng Jiyan Intelligent Technology Co., Ltd., established on 2019-12-27, Business scope includes smart terminal equipment,communication device,broadband multimedia equipment,power supply,electronic product,software,Computer and supporting equipment,Research and development of general machinery and equipment,Sales,detection,Technical Services,technical consulting;Information system design,integrated,Operation and Maintenance;IC Design,research and development;Intellectual Property Agency Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)